Back to all people

Gregory Levin

FDA

2 appearances in the program

Sessions & presentations

PS35: One Drug, Two Agencies: FDA and EMA. Similarities, Differences, Learning from One Another

Presentation: Experience with Developing a Drug Globally: Panel Discussion

Parallel · Fri, Sep 18 , 10:45 AM

Panelist

PS10: Strategies to Assess the Impact of Informative Missingness in Regulatory Submissions for Time-to-Event Trials

Presentation: A Regulatory Perspective on Missing Data Sensitivity Analyses

Parallel · Thu, Sep 17 , 2:45 PM

Presenting Author

↑